Recombinant human neuregulin-1 alleviates immobilization-induced neuromuscular dysfunction via neuregulin-1/ErbB signaling pathway in rat.

[1]  G. Van den Berghe,et al.  ICU-acquired weakness , 2020, Intensive Care Medicine.

[2]  S. Min,et al.  Alleviating Sepsis-Induced Neuromuscular Dysfunction Linked With Acetylcholine Receptors by Agrin. , 2019, The Journal of surgical research.

[3]  S. Min,et al.  Enhancing Autophagy Protects Against Sepsis-Induced Neuromuscular Dysfunction Associated with Qualitative Changes to Acetylcholine Receptors. , 2019, Shock.

[4]  Hua Liu,et al.  Neuregulin-1β attenuates sepsis-induced diaphragm atrophy by activating the PI3K/Akt signaling pathway , 2019, Journal of Muscle Research and Cell Motility.

[5]  J. Thliveris,et al.  Neuregulin‐1 promotes remyelination and fosters a pro‐regenerative inflammatory response in focal demyelinating lesions of the spinal cord , 2018, Glia.

[6]  S. Min,et al.  Glial cell-derived neurotrophic factor alleviates sepsis-induced neuromuscular dysfunction by decreasing the expression of γ- and α7-nicotinic acetylcholine receptors in an experimental rat model of neuromyopathy. , 2018, Biochemical and biophysical research communications.

[7]  D. Intiso.  ICU-acquired weakness: should medical sovereignty belong to any specialist? , 2018, Critical Care.

[8]  D. Needham,et al.  Recovery after critical illness: putting the puzzle together—a consensus of 29 , 2017, Critical Care.

[9]  S. Min,et al.  Electroacupuncture alleviates neuromuscular dysfunction in an experimental rat model of immobilization , 2017, Oncotarget.

[10]  F. Zhang,et al.  Burn-related peripheral neuropathy: A systematic review. , 2017, Burns : journal of the International Society for Burn Injuries.

[11]  P. Pronovost,et al.  Muscle Weakness and 5-Year Survival in Acute Respiratory Distress Syndrome Survivors* , 2017, Critical care medicine.

[12]  E. Jaimovich,et al.  Interleukin-6 and neuregulin-1 as regulators of utrophin expression via the activation of NRG-1/ErbB signaling pathway in mdx cells. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[13]  C. Hough,et al.  ICU-Acquired Weakness. , 2016, Chest.

[14]  C. Umscheid,et al.  Neuromuscular Blocking Agents and Neuromuscular Dysfunction Acquired in Critical Illness: A Systematic Review and Meta-Analysis , 2016, Critical care medicine.

[15]  M. Blobner,et al.  Neuromuscular Recovery Is Prolonged After Immobilization or Superimposition of Inflammation With Immobilization Compared to Inflammation Alone: Data From a Preclinical Model , 2016, Critical care medicine.

[16]  X. Navarro,et al.  Neuregulin-1 promotes functional improvement by enhancing collateral sprouting in SOD1G93A ALS mice and after partial muscle denervation , 2016, Neurobiology of Disease.

[17]  Seong-Woo Jeong,et al.  Neuregulin 1 as an endogenous regulator of nicotinic acetylcholine receptors in adult major pelvic ganglion neurons. , 2015, Biochemical and biophysical research communications.

[18]  L. Tintignac,et al.  Mechanisms Regulating Neuromuscular Junction Development and Function and Causes of Muscle Wasting. , 2015, Physiological reviews.

[19]  K. Nave,et al.  Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A , 2014, Nature Medicine.

[20]  H. Park,et al.  Mitogen Activated Protein Kinase Family Proteins and c-jun Signaling in Injury-induced Schwann Cell Plasticity , 2014, Experimental neurobiology.

[21]  M. Moss,et al.  Screening for critical illness polyneuromyopathy with single nerve conduction studies , 2014, Intensive Care Medicine.

[22]  M. Kaneki,et al.  Immobilization with Atrophy Induces De Novo Expression of Neuronal Nicotinic &agr;7 Acetylcholine Receptors in Muscle Contributing to Neurotransmission , 2014, Anesthesiology.

[23]  O. Erbaş,et al.  Comparison of melatonin and oxytocin in the prevention of critical illness polyneuropathy in rats with experimentally induced sepsis. , 2013, The Journal of surgical research.

[24]  Seong-Woo Jeong,et al.  Neuregulin 1 up‐regulates the expression of nicotinic acetylcholine receptors through the ErbB2/ErbB3‐PI3K‐MAPK signaling cascade in adult autonomic ganglion neurons , 2013, Journal of neurochemistry.

[25]  Angela Lipshutz,et al.  Acquired Neuromuscular Weakness and Early Mobilization in the Intensive Care Unit , 2013, Anesthesiology.

[26]  N. Ip,et al.  Molecular mechanisms underlying maturation and maintenance of the vertebrate neuromuscular junction , 2012, Trends in Neurosciences.

[27]  H. Brenner,et al.  Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin , 2011, The Journal of cell biology.

[28]  C. Bolton,et al.  Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis , 2011, The Lancet Neurology.

[29]  D. Remick,et al.  Noninvasive model of sciatic nerve conduction in healthy and septic mice: Reliability and normative data , 2009, Muscle & nerve.

[30]  L. Eriksson,et al.  Basic principles of neuromuscular transmission , 2009, Anaesthesia.

[31]  C. Herndon,et al.  Neuregulin‐1 induces acetylcholine receptor transcription in the absence of GABPα phosphorylation , 2008, Journal of neuroscience research.

[32]  J. Martyn,et al.  Systemic inflammatory response syndrome increases immobility-induced neuromuscular weakness* , 2008, Critical care medicine.

[33]  G. Lagoumintzis,et al.  Muscle and neuronal nicotinic acetylcholine receptors , 2007 .

[34]  M. Rimer.  Neuregulins at the neuromuscular synapse: Past, present, and future , 2007, Journal of neuroscience research.

[35]  T. Kubo,et al.  Increased expression of neuregulin-1 in differentiating muscle satellite cells and in motoneurons during muscle regeneration , 2007, Acta Neuropathologica.

[36]  C. Mantilla,et al.  Neuregulin-dependent protein synthesis in C2C12 myotubes and rat diaphragm muscle. , 2006, American journal of physiology. Cell physiology.

[37]  J. Lindstrom.  Nicotinic Acetylcholine Receptors of Muscles and Nerves , 2003 .

[38]  J. A. Dani,et al.  Mouse muscle denervation increases expression of an α7 nicotinic receptor with unusual pharmacology , 2003, The Journal of physiology.

[39]  S. Arber,et al.  A Role for Neuregulin1 Signaling in Muscle Spindle Differentiation , 2002, Neuron.

[40]  M. Rudnicki,et al.  ErbB2 Is Required for Muscle Spindle and Myoblast Cell Survival , 2002, Molecular and Cellular Biology.

[41]  S. Burden,et al.  Neuregulin-1-stimulated phosphorylation of GABP in skeletal muscle cells. , 2001, Biochemistry.

[42]  A. Maelicke,et al.  Expression of functional α7 nicotinic acetylcholine receptor during mammalian muscle development and denervation , 1999, The European journal of neuroscience.

[43]  J. Trachtenberg.  Fiber apoptosis in developing rat muscles is regulated by activity, neuregulin. , 1998, Developmental biology.

[44]  C. Ibebunjo,et al.  Mechanisms for the paradoxical resistance to d-tubocurarine during immobilization-induced muscle atrophy. , 1997, The Journal of pharmacology and experimental therapeutics.

[45]  S. von Haehling.  ICU-acquired weakness and recovery from critical illness. , 2014, The New England journal of medicine.

[46]  M. Kaneki,et al.  Nonsurgically induced disuse muscle atrophy and neuromuscular dysfunction upregulates alpha7 acetylcholine receptors. , 2014, Canadian journal of physiology and pharmacology.

[47]  B. Wang,et al.  Pharmacodynamic changes with vecuronium in sepsis are associated with expression of α7- and γ-nicotinic acetylcholine receptor in an experimental rat model of neuromyopathy. , 2014, British journal of anaesthesia.

[48]  E. Albuquerque,et al.  Mammalian nicotinic acetylcholine receptors: from structure to function. , 2009, Physiological reviews.

[49]  Stefan Britsch,et al.  The neuregulin-I/ErbB signaling system in development and disease. , 2007, Advances in anatomy, embryology, and cell biology.